SAGE - Sage Therapeutics, Inc.
8.68
-0.020 -0.230%
Share volume: 22,698,684
Last Updated: 07-30-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$8.70
-0.02
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | |
| Report Date | 04-25-2024 | 07-31-2024 | 10-29-2024 | 02-11-2025 | 04-29-2025 | 07-30-2025 | |
| Assets | |||||||
| Total Assets | 767.600 M | 697.105 M | 622.432 M | 547.222 M | 469.669 M | 422.922 M | |
| Current Assets | 755.442 M | 686.811 M | 604.987 M | 531.301 M | 454.476 M | 409.085 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 26.588 M | 28.743 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 26.588 M | 28.743 M | 469.527 M | 423.397 M | 378.630 M | 298.085 M | |
| Total Receivables | 10.509 M | 9.943 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 717.013 M | 646.793 M | 99.627 M | 81.021 M | 45.224 M | 67.487 M | |
| Total Non-current Assets | 12.158 M | 10.294 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 1.585 M | 1.274 M | 1.019 M | 890.000 K | 778.000 K | 674.000 K | |
| Other Assets | 6.216 M | 7.800 M | 16.426 M | 15.031 M | 14.415 M | 13.163 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 767.600 M | 697.105 M | 622.432 M | 547.222 M | 469.669 M | 422.922 M | |
| Total liabilities | 61.799 M | 69.043 M | 70.597 M | 82.133 M | 59.821 M | 54.185 M | |
| Total current liabilities | 61.799 M | 69.043 M | 60.406 M | 71.615 M | 49.778 M | 44.642 M | |
| Accounts Payable | 6.479 M | 8.650 M | 7.126 M | 12.699 M | 5.435 M | 692.000 K | |
| Other liabilities | 0.000 | 0.000 | 10.191 M | 10.518 M | 10.043 M | 9.543 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 10.191 M | 10.518 M | 10.043 M | 9.543 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 705.801 M | 628.062 M | 551.835 M | 465.089 M | 409.848 M | 368.737 M | |
| Common stock | 60.136 M | 60.538 M | 3.426 B | 3.436 B | 3.443 B | 3.451 B | |
| Retained earnings | -2.678 B | -2.781 B | -2.875 B | -2.970 B | -3.033 B | -3.082 B |